The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Amlodipine besylate and Atorvastatin calcium
Amlodipine besylate and Atorvastatin calcium · AMLODIPINE BESYLATE 5 mg/1; ATORVASTATIN CALCIUM TRIHYDRATE 20 mg/1 · Tablet, Film Coated · Oral · Dr. Reddy's Laboratories Inc
NDC 43598-0319-05 · 500 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 43598-0319-30) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$1.35per unit
middle half $0.5970–$1.76 · 4,446 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $1.35
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
81%of plans cover it
tier 1 · prior auth 0% · step therapy 0% · qty limit 38%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA203874
- TE code
- AB
- Approval date
- Mar 7, 2014
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class III · TerminatedAug 13, 2015Dr. Reddy's Laboratories, Inc. — Subpotent Drug: Subpotent atorvastatin.
- Class III · TerminatedAug 13, 2015Dr. Reddy's Laboratories, Inc. — Subpotent Drug: Subpotent atorvastatin.
- Class III · TerminatedAug 13, 2015Dr. Reddy's Laboratories, Inc. — Subpotent Drug: Subpotent atorvastatin.
- Class III · TerminatedAug 13, 2015Dr. Reddy's Laboratories, Inc. — Subpotent Drug: Subpotent atorvastatin.
- Class III · TerminatedAug 13, 2015Dr. Reddy's Laboratories, Inc. — Subpotent Drug: Subpotent atorvastatin.
- Class III · TerminatedAug 13, 2015Dr. Reddy's Laboratories, Inc. — Subpotent Drug: Subpotent atorvastatin.
- Class III · TerminatedAug 13, 2015Dr. Reddy's Laboratories, Inc. — Subpotent Drug: Subpotent atorvastatin.
- Class III · TerminatedMay 6, 2015Dr. Reddy's Laboratories, Inc. — Subpotent drug
- Class III · TerminatedMay 6, 2015Dr. Reddy's Laboratories, Inc. — Subpotent drug
- Class III · TerminatedMay 6, 2015Dr. Reddy's Laboratories, Inc. — Subpotent drug
- Class III · TerminatedMay 6, 2015Dr. Reddy's Laboratories, Inc. — Subpotent drug
Manufacturers of Amlodipine besylate and Atorvastatin calcium (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Dr. Reddy's Laboratories Inc | AMLODIPINE BESYLATE 10 mg/1; ATORVASTATIN CALCIUM TRIHYDRATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc | AMLODIPINE BESYLATE 10 mg/1; ATORVASTATIN CALCIUM TRIHYDRATE 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc | AMLODIPINE BESYLATE 10 mg/1; ATORVASTATIN CALCIUM TRIHYDRATE 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc | AMLODIPINE BESYLATE 10 mg/1; ATORVASTATIN CALCIUM TRIHYDRATE 80 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc | AMLODIPINE BESYLATE 2.5 mg/1; ATORVASTATIN CALCIUM TRIHYDRATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc | AMLODIPINE BESYLATE 2.5 mg/1; ATORVASTATIN CALCIUM TRIHYDRATE 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc | AMLODIPINE BESYLATE 2.5 mg/1; ATORVASTATIN CALCIUM TRIHYDRATE 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc | AMLODIPINE BESYLATE 5 mg/1; ATORVASTATIN CALCIUM TRIHYDRATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc | AMLODIPINE BESYLATE 5 mg/1; ATORVASTATIN CALCIUM TRIHYDRATE 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc | AMLODIPINE BESYLATE 5 mg/1; ATORVASTATIN CALCIUM TRIHYDRATE 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dr. Reddy's Laboratories Inc | AMLODIPINE BESYLATE 5 mg/1; ATORVASTATIN CALCIUM TRIHYDRATE 80 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Amlodipine besylate and Atorvastatin calcium — NDC 43598-0319-05," retrieved September 3, 2026, https://drugdashboards.com/drug/43598031905.
Free to cite with attribution — see how the data is put together.